Innovation in Pharma

The consequences of consuming synthetic drugs (chemicals) are aplenty. The instances of pharmacovigilance keep surfacing, and they tarnish brand value which has long-lasting impact for a pharmaceutical company. As a result, most players developing drugs for complex diseases have ventured into discovering biologics – an equivalent of the chemical drug derived from biological sources. While a large number of these drugs are available in the market today are proving to